A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
NCT03165422
·
clinicaltrials.gov ↗
COMPLETED
Status
68
Enrollment
INDUSTRY
Sponsor class
Conditions
Melanoma
Interventions
OTHER:
Non-Interventional
Sponsor
Bristol-Myers Squibb
Collaborators
[object Object]